Skip to main content
Livermore
Livermore
ZHEN

Viatris Inc

VTRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001792044

No open-market purchases or sales by Viatris Inc insiders were filed in the last 90 days; 1,032 institutions reported holding it in 13F filings for Q2 2026, worth $16.6B in total; Greenlight Capital is the only superinvestor holding it.

Holders of 5% or more of VTRS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Viatris Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of VTRS
HolderLatest formStakeChangeFirst filedLatest filingFiling
Price T Rowe Associates Inc13G6.30%74.7M sharesNewMay 14, 20251 filingMay 14, 2025SEC
Davis Selected Advisers13G/A6.20%66.4M shares+0.20 ppfrom 6.00%Jan 24, 20253 filingsAug 7, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on Viatris Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on VTRS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 11, 20258:26 AM ETState Street Corp13G4.70%55.3M sharesNewBelow 5%Jun 30, 2025SEC
Aug 7, 202510:29 AM ETDavis Selected Advisers13G/A6.20%66.4M shares+0.20 ppfrom 6.00%Jun 30, 2025SEC
May 14, 202510:45 AM ETPrice T Rowe Associates Inc13G6.30%74.7M sharesNewMar 31, 2025SEC
May 8, 202510:20 AM ETDavis Selected Advisers13G/A6.00%64.9M shares+0.10 ppfrom 5.90%Mar 31, 2025SEC
Jan 24, 20253:39 PM ETDavis Selected Advisers13G5.90%62.6M sharesNewDec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Viatris Inc shares.

No Form 144 notices for Viatris Inc are on file.